Business Description
MindBio Therapeutics Corp
NAICS : 541714
SIC : 3741
ISIN : CA60256C1086
Compare
Compare
Traded in other countries / regions
MBIO.CanadaWF6.Germany IPO Date
2023-05-05Description
MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -37.81 | |||||
| Debt-to-Equity | -0.89 | |||||
| Debt-to-EBITDA | -1.48 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -204.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.35 | |||||
| 9-Day RSI | 49.04 | |||||
| 14-Day RSI | 49.68 | |||||
| 6-1 Month Momentum % | 66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | |||||
| Quick Ratio | 0.1 | |||||
| Cash Ratio | 0.08 | |||||
| Days Sales Outstanding | 2.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.57 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1531.64 | |||||
| Net Margin % | -1980.79 | |||||
| FCF Margin % | -763.28 | |||||
| ROA % | -654.35 | |||||
| ROIC % | -225.5 | |||||
| ROC (Joel Greenblatt) % | -612.82 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 55 | |||||
| EV-to-EBIT | -3.76 | |||||
| EV-to-EBITDA | -3.84 | |||||
| EV-to-Revenue | 65.94 | |||||
| EV-to-FCF | -8.64 | |||||
| Earnings Yield (Greenblatt) % | -26.6 | |||||
| FCF Yield % | -18.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MindBio Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.177 | ||
| EPS (TTM) (C$) | -0.026 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 49.68 | ||
| 14-Day ATR (C$) | 0.005815 | ||
| 20-Day SMA (C$) | 0.054 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.015 - 0.56 | ||
| Shares Outstanding (Mil) | 133.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MindBio Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MindBio Therapeutics Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
MindBio Therapeutics Corp Frequently Asked Questions
What is MindBio Therapeutics Corp(XCNQ:MBIO)'s stock price today?
The current price of XCNQ:MBIO is C$0.06. The 52 week high of XCNQ:MBIO is C$0.56 and 52 week low is C$0.02.
When is next earnings date of MindBio Therapeutics Corp(XCNQ:MBIO)?
The next earnings date of MindBio Therapeutics Corp(XCNQ:MBIO) is .
Does MindBio Therapeutics Corp(XCNQ:MBIO) pay dividends? If so, how much?
MindBio Therapeutics Corp(XCNQ:MBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers